Ardent Health, Inc. (ARDT)
(Delayed Data from NYSE)
$10.65 USD
+0.34 (3.30%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $10.66 +0.01 (0.09%) 6:42 PM ET
4-Sell of 5 4
A Value B Growth A Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Ardent Health, Inc. has a PEG ratio of 5.07 compared to the Medical Services industry's PEG ratio of 1.54.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ARDT 10.65 +0.34(3.30%)
Will ARDT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ARDT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ARDT
Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: Should You Buy?
Bausch + Lomb (BLCO) Q2 Earnings and Revenues Surpass Estimates
ARDT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Analysts Estimate Ardent Health, Inc. (ARDT) to Report a Decline in Earnings: What to Look Out for
Wall Street Analysts Predict a 36.55% Upside in Ardent Health Partners, Inc. (ARDT): Here's What You Should Know
The Zacks Analyst Blog Highlights Amgen, Cencora, Humana and Ardent Health
Other News for ARDT
ARDT Forecasts FY25 Revenue Growth
Ardent Health Partners Non-GAAP EPS of $0.52 beats by $0.20, revenue of $1.65B beats by $120M
Ardent Health (ARDT) Reports Strong Q2 Financial Performance
Ardent Health Reports Second Quarter 2025 Results | ARDT Stock News
Earnings Scheduled For August 5, 2025